Cameron's Research Fund Gives $100,000 to Advance Ependymoma Research

The Cameron Corno Research Fund at the Lilabean Foundation is giving $100,000 to the Children's Brain Tumor Network (CBTN) to test a new immunotherapy for children whose ependymoma recurs.


What this gift supports

When ependymoma returns, children have very few treatments that work. This gift will advance a project led by Dr. Peter Madsen at Children's Hospital of Philadelphia (CHOP) to test a new CAR T cell therapy developed by Dr. Leyuan Ma.


CAR T therapy trains a patient's own immune cells to find and attack cancer. The team will first test Dr. Ma's CAR T cells on patient-derived ependymoma tumoroids: lab-grown models built from real children's tumors. If those results are promising, the next step is testing the approach in mouse models.


Because the tumoroids and the research infrastructure already exist through CHOP and CBTN, the team can start right away. They won't need to spend the first years building tools. They can go straight to the question families currently facing a diagnosis are asking, “Could this work for my child?”


Why every answer moves research forward

This project will show whether Dr. Ma's approach should advance toward treatment for recurrent ependymoma. Either outcome has value.


If the results are strong, the therapy moves a step closer to becoming a reliable treatment option for children facing recurrent ependymoma. If they reveal limits, researchers, doctors, and funders learn where not to spend precious time and money. That focus speeds progress toward safer, more effective treatments.


Cameron is still helping researchers today

Cameron's impact reaches beyond this gift. She was enrolled in CBTN from the day she was diagnosed, so the network captured clinical information across her entire journey, including data from her care.


Those de-identified data remain available to researchers and can help answer new questions for years to come. Some of Cameron's tissue samples also remain in the CBTN biobank. A single tissue donation can fuel many studies over time, from new types of data to research approaches that don't exist yet.

A research model grown from Cameron's tissue also exists at Children's National Hospital. The team is now exploring whether it could play a role in this project.


Thank you, Cam's Crew

This $100,000 gift was made possible because of you. Every birthday donation, every tribute gift and every shared post builds Cameron's Research Fund into a force for children facing ependymoma and continues Cameron’s impact.

Title text on dark blue: “Memories from a Hero’s Grandpa” by Jay Spitulnik
August 10, 2026
August marks one year since we lost Kasey Vivian Zachmann. She was 10 years old. Over the course of four years, Kasey endured 10 surgeries, 45 proton radiation treatments, multiple rounds of chemotherapy, and two clinical trials, and through all of it, she never lost her smile. To mark this anniversary, we are honored to share a reflection written by Jay Spitulnik, Kasey's maternal grandfather. Jay's words carry the kind of love and clarity that only comes from someone who was there, someone who watched Kasey light up every room she entered, and who has spent the past year learning to carry both grief and pride in equal measure. The Kasey Zachmann Fund for Medulloblastoma Research was established in her honor to ensure her fight advances the science for every child who comes after her. We hope Jay's reflection touches your heart as it has ours.
Blue title card reading “Driving Hope, Coming Full Circle” by Kelly Barch.
By Kelly Barch, Executive Director of the Lilabean Foundation • July 29, 2026
Thirteen years ago, my dad passed away from cancer. Long before that, he'd spent years at Herson's Honda teaching sales after starting his second career. When I was old enough to drive, my very first car was a Honda Civic from that same lot.
Trip to See My Daughter text in yellow on blue background
May 15, 2026
Recently, members of the Lilabean Foundation team had the opportunity to visit Children’s Hospital of Philadelphia (CHOP) and spend time with researchers and leaders from the Children’s Brain Tumor Network (CBTN).
SHOW MORE